儿童呼吸衰竭体外膜氧合:重症医生与基层儿科医生的衔接综述
本综述指出儿童呼吸衰竭使用ECMO虽不频繁但量与肾/心脏移植相当,成人及新生儿ECMO试验不能直接外推至非新生儿儿童,所有儿科医生应关注ECMO幸存者的神经发育筛查与随访。
要点
- 儿童呼吸衰竭ECMO使用量与肾或心脏移植相当,但非新生儿儿童缺乏呼吸ECMO临床试验。
- 新生儿和年长儿童均有颅内出血、缺血性卒中、惊厥等神经并发症风险,可致神经发育不良。
- 所有儿科医生应了解ECMO获益与并发症,并确保幸存者获得有效筛查、支持和随访。
核心结论
- 所有儿科医生应知晓ECMO的潜在获益与并发症,并认识到幸存者需要有效的筛查、支持和随访。
研究设计与样本
- 本文为综述,基于成人呼吸ECMO随机临床试验、新生儿ECMO随机临床试验及2009年甲型H1N1流感大流行相关证据进行总结。
主要发现
- 2009年甲型H1N1流感大流行及成人呼吸ECMO随机临床试验推动了ECMO使用的持续增长。
- 成人试验建立在早期新生儿ECMO随机临床试验基础上,后者显示严重围产期肺病生存改善。
- 非新生儿期儿童似乎没有呼吸ECMO临床试验,将成人或围产期肺病证据外推至该人群存在重要潜在陷阱。
- 非新生儿儿童的基础疾病和ECMO风险与新生儿不同,但两者均有颅内出血、缺血性卒中、惊厥等神经并发症风险。
- 若无特定筛查,细微神经发育损害可能被漏诊,但识别后儿童有机会接受治疗以优化长期发育。
临床怎么用
- 儿科医生应了解ECMO的潜在获益与并发症,并关注幸存者的神经发育筛查、支持和随访。
局限性
- 非新生儿期儿童缺乏呼吸ECMO临床试验,将成人或围产期肺病证据外推至该人群存在重要潜在陷阱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Extracorporeal membrane oxygenation (ECMO) is a form of advanced life support that may be used in children with refractory respiratory or cardiac failure. While it is required infrequently, in the US, ECMO is used to support childhood respiratory failure as often as children receive kidney or heart transplants. ECMO is complex, resource intensive, and potentially lifesaving, but it is also associated with risks of short-term complications and long-term adverse effects, most importantly with neurodevelopmental outcomes that are relevant to all pediatric clinicians, even those remote from the child's critical illness. OBSERVATIONS: The 2009 influenza A(H1N1) pandemic, along with randomized clinical trials of adult respiratory ECMO support and conventional management, have catalyzed sustained growth in the use of ECMO. The adult trials built on earlier neonatal ECMO randomized clinical trials that demonstrated improved survival in severe perinatal lung disease. For children outside of the neonatal period, there appear to have been no respiratory ECMO clinical trials. Applying evidence from adult respiratory failure or perinatal lung disease to children outside the neonatal period has important potential pitfalls. For these children, the underlying diseases and risks of ECMO are different. Despite these differences, both neonates and older children are at risk of neurologic complications, such as intracranial hemorrhage, ischemic stroke, and seizures, and those complications may contribute to adverse neurodevelopmental outcomes. Without specific screening, subtle neurodevelopmental impairments may be missed, but when they are identified, children have the opportunity to receive therapy to optimize long-term development. CONCLUSIONS AND RELEVANCE: All pediatric clinicians should be aware not only of the potential benefits and complications of ECMO but also that survivors need effective screening, support, and follow-up.
引用
- Barbaro RP, Brodie D, MacLaren G, et al. Bridging the Gap Between Intensivists and Primary Care Clinicians in Extracorporeal Membrane Oxygenation for Respiratory Failure in Children: A Review. JAMA Pediatr. 2021. PMID: 33646287. doi:10.1001/jamapediatrics.2020.5921
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。